NLN expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.018600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.523600E-01
Normal-vs-Stage2
7.858000E-01
Normal-vs-Stage3
1.943230E-01
Normal-vs-Stage4
5.136400E-01
Stage1-vs-Stage2
6.051200E-01
Stage1-vs-Stage3
1.710030E-01
Stage1-vs-Stage4
1.221790E-01
Stage2-vs-Stage3
1.294820E-01
Stage2-vs-Stage4
1.111380E-01
Stage3-vs-Stage4
5.119600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.946800E-01
Normal-vs-AfricanAmerican
9.703600E-01
Normal-vs-Asian
5.043600E-01
Caucasian-vs-AfricanAmerican
6.258800E-01
Caucasian-vs-Asian
3.237000E-01
AfricanAmerican-vs-Asian
3.771200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.773600E-01
Normal-vs-Female
8.387000E-01
Male-vs-Female
3.177200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.084600E-01
Normal-vs-Age(41-60Yrs)
7.432600E-01
Normal-vs-Age(61-80Yrs)
6.677200E-01
Normal-vs-Age(81-100Yrs)
9.816800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.641400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.824400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.717200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.246000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.480200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.909600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.602000E-01
Normal-vs-Daily Drinker
6.495000E-01
Normal-vs-Weekly Drinker
5.885000E-01
Normal-vs-Occasional Drinker
8.511800E-01
Normal-vs-Social Drinker
6.537800E-01
Non Drinker-vs-Daily Drinker
9.714400E-01
Non Drinker-vs-Weekly Drinker
8.957400E-01
Non Drinker-vs-Occasional Drinker
2.031400E-01
Non Drinker-vs-Social Drinker
7.227000E-01
Daily Drinker-vs-Weekly Drinker
9.235000E-01
Daily Drinker-vs-Occasional Drinker
2.166400E-01
Daily Drinker-vs-Social Drinker
7.136400E-01
Weekly Drinker-vs-Occasional Drinker
2.185600E-01
Weekly Drinker-vs-Social Drinker
6.421000E-01
Occasional Drinker-vs-Social Drinker
2.889800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.115000E-01
Normal-vs-Grade 2
1.689750E-01
Normal-vs-Grade 3
1.111010E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.009540E-02
Grade 1-vs-Grade 3
7.036300E-04
Grade 1-vs-Grade 4
4.115000E-01
Grade 2-vs-Grade 3
1.260830E-01
Grade 2-vs-Grade 4
1.689750E-01
Grade 3-vs-Grade 4
1.111010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.878200E-01
Normal-vs-NonDiabetic
7.036800E-01
Diabetic-vs-NonDiabetic
9.154200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.169200E-01
Normal-vs-NoPancreatitis
7.790600E-01
Pancreatitis-vs-NoPancreatitis
3.953600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.439400E-01
Normal-vs-N1
8.497800E-01
N0-vs-N1
8.086400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.812800E-01
Normal-vs-TP53-NonMutant
4.610000E-01
TP53-Mutant-vs-TP53-NonMutant
2.997200E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
